Clinical Trial Update: Stereotactic Radiosurgery Versus Radiofrequency Ablation for Primary Liver Cancer [Phase 2]

View source ↗

Summary

This Phase 2 trial update indicates recruitment is ongoing to compare stereotactic radiosurgery versus radiofrequency ablation for hepatocellular carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Snippet

Sponsor: Tianjin Medical University Cancer Institute and Hospital | Conditions: Primary Liver Cancer | Phase 2 | Status: RECRUITING